Log In
Print
BCIQ
Print
Print this Print this
 

TSR-011

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionSmall molecule inhibitor of anaplastic lymphoma kinase (ALK), neurotrophic tyrosine kinase receptor 1 (NTRK1; TrkA), TrkB and TrkC
Molecular Target Anaplastic lymphoma kinase (ALK) ; Neurotrophic tyrosine kinase receptor 1 (NTRK1) (TrkA)
Mechanism of ActionAnaplastic lymphoma kinase (Ki-1) (ALK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today